Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Cipla
Covington
Farmers Insurance
Chinese Patent Office
Daiichi Sankyo
Healthtrust
US Department of Justice
Boehringer Ingelheim

Generated: July 23, 2018

DrugPatentWatch Database Preview

ROXYBOND Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Roxybond, and when can generic versions of Roxybond launch?

Roxybond is a drug marketed by Daiichi Sankyo Inc and is included in one NDA. There is one patent protecting this drug.

This drug has nineteen patent family members in eight countries.

The generic ingredient in ROXYBOND is oxycodone hydrochloride. There are nineteen drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.
Summary for ROXYBOND
International Patents:19
US Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: 2
Formulation / Manufacturing:see details
DailyMed Link:ROXYBOND at DailyMed
Drug patent expirations by year for ROXYBOND
Pharmacology for ROXYBOND
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

US Patents and Regulatory Information for ROXYBOND

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Daiichi Sankyo Inc ROXYBOND oxycodone hydrochloride TABLET;ORAL 209777-001 Apr 20, 2017 RX No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Daiichi Sankyo Inc ROXYBOND oxycodone hydrochloride TABLET;ORAL 209777-002 Apr 20, 2017 RX No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Daiichi Sankyo Inc ROXYBOND oxycodone hydrochloride TABLET;ORAL 209777-003 Apr 20, 2017 RX No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

Supplementary Protection Certificates for ROXYBOND

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
292 Luxembourg ➤ Sign Up PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
McKesson
Citi
US Army
Federal Trade Commission
Baxter
UBS
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.